Apple has announced three unprecedented medical studies, in partnershi...
SpePharm AG, a subsidiary of Norgine B.V., announced that the Uni...
Novo Nordisk is expanding the company's affordability offering in the ...
Recently the National Institutes of Health (NIH) called on researchers...
Scientists from the National Institutes of Health and Cincinnati Child...
The Merck Foundation (the Foundation) has launched HIV Care Connect, a...
Vertex Pharmaceuticals Incorporated has entered into a definitive agre...
BioCity, the pioneering life science incubator and business collective...
Allergan plc has received U.S. Food and Drug Administration (FDA) appr...
Sandoz, a Novartis division and a global leader in biosimilars, has en...
Robocath, a company that designs, develops and commercializes cardiova...
A WHO expert advisory committee has approved the first phase of a new ...
LindaCare announced that it is collaborating with Philips to...
Roche has announced that the European Commission has approved Tecentri...
Ionis Pharmaceuticals, the leader in RNA-targeted therapeutics, announ...
Amgen has entered into an agreement with Celgene Corporation...
Viralgen and AskBio announced that Viralgen has received Cur...
Velabs Therapeutics (Velabs), specializing in the fast generation of f...
